Recombinant Human Granulocyte Colony-stimulating Factor Injection

北京双鹭药业股份有限公司🇨🇳 National Medical Products Administration

Approval Id: 7LeaeJkSYNT
Approval Number: 国药准字S20030049
Generic Name: 重组人粒细胞刺激因子注射液
Generic Name En: Recombinant Human Granulocyte Colony-stimulating Factor Injection
Trade Name: 立生素
Brand Name: 立生素
Drug Type: 生物制品
Dosage Form: 注射剂(小容量注射剂)
Strength: 200μg/瓶
Reg Date: 2020-09-11
Company Name: 北京双鹭药业股份有限公司
Company Address: 北京市海淀区阜石路69号碧桐园1号楼4层
Production Company Name: 北京双鹭药业股份有限公司
Production Company Address: 北京市石景山区八大处高科技园区中园路9号
Company Detail Path: /organization/beijing-sl-pharmaceutical-co-ltd
Production Company Detail Path: /organization/beijing-sl-pharmaceutical-co-ltd

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 11, 2020

Approval ID

7LeaeJkSYNT

Type

生物制品